BD-3

• Description :

  Defensins (alpha and beta) are cationic peptides with a broad spectrum of antimicrobial activity that comprise an important arm of the innate immune system. The α-defensins are distinguished from the β-defensins by the pairing of their three disulfide bonds. To date, six human β-defensins have been identified; BD-1, BD-2, BD-3, BD-4, BD-5 and BD-6. β-defensins are expressed on some leukocytes and at epithelial surfaces. In addition to their direct antimicrobial activities, they can act as chemoattractants towards immature dendritic cells and memory T cells. The β-defensin proteins are expressed as the C-terminal portion of precursors, and are released by proteolytic cleavage of a signal sequence and, in some cases, a propeptide sequence. β-defensins contain a six-cysteine motif that forms three intra-molecular disulfide bonds. Recombinant Murine BD-3 is a 4.6 kDa protein containing 41 amino acid residues.

• Synonyms :

  Beta-Defensin 3, DEFB3, DEFB103A

• NCBI Gene ID :

  27358

• UniProt :

  Q9WTL0

• Accession Number :

  NP_038784.1

• Accession Number mRNA :

  NM_013756.2

• Reactivity :

  Mouse

• Cross Reactivity :

  Mouse

• Sequence :

  KKINNPVSCL RKGGRCWNRC IGNTRQIGSC GVPFLKCCKR K

• Endotoxin :

  < 0.1 ng/µg of protein (< 1EU/µg)

• Purity :

  ≥ 98% by SDS-PAGE gel and HPLC analyses

• Bioactivity :

  Not available.

• Length :

  41

• Form :

  Lyophilized

• Molecular Weight :

  4.6 kDa

• Host or Source :

  E. coli